Troparin 3000 IU Injection

Manufactured byNovartis India Ltd.
ContainsCertoparin
Description

Troparin 3000 IU Injection is an anticoagulant used to prevent the formation of blood clots in patients undergoing certain specific medical procedures.

Substitutes

List of substitutes for Troparin 3000 IU Injection

Side effects

Major & minor side effects for Troparin 3000 IU Injection

  • Injection site redness, bruising, or sores
  • Unusual bleeding or bruising
  • Bloody or coffee colored vomit
  • Black or tarry stools
  • Difficulty in breathing
  • Temporary hair loss
  • Fragile or brittle bones
  • Allergic skin reaction
  • Back pain
  • Muscle weakness
  • Burning or tingling sensation of skin
  • Increased potassium levels

Uses of Troparin 3000 IU Injection

What is it prescribed for?

  • Prevention of venous thromboembolic events after surgery
Read More
Concerns

Commonly asked questions

  • Onset of action
    The effect of this medicine can be observed within 1-3 hours of administration.
  • Duration of effect
    The effect of this medicine lasts for an average duration of 8-10 hours.
  • Safe with alcohol?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is it habit forming?
    No habit forming tendencies were reported.
  • Usage in pregnancy?
    This medicine is not recommended for use in pregnant women since the safety and efficacy are not clinically established.
  • Usage while breast-feeding?
    This medicine is not recommended for use in breastfeeding women since the safety and efficacy are not clinically established.

Allergy

This medicine is not recommended for use in patients with a known allergy to certoparin or any other inactive ingredient present along with it. Use of this medicine is also not recommended in patients having a known allergy to heparin or pork products.

Active major bleeding

This medicine is not recommended for use in patients with a known heavy active bleeding due to the increased risk of worsening of the patient's condition.

Thrombocytopenia

This medicine is not recommended for use in patients with an abnormally low platelet count due to the increased risk of excessive bleeding.

Bacterial endocarditis

This medicine is not recommended for use in patients having a swelling of the heart walls or valves due to bacterial infections (bacterial endocarditis).

Hemorrhagic cardiovascular events

This medicine is not recommended for use in patients who are at an increased risk of internal bleeding or hemorrhages due to the risk of worsening of the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women since the safety and efficacy are not clinically established.

Breast-feeding

This medicine is not recommended for use in breastfeeding women since the safety and efficacy are not clinically established.
General warnings

Hemorrhage and risk factors

Use of this medicine should be initiated only after internal bleeding or hemorrhage and associated risk factors are ruled out. All the underlying causes of bleeding such as peptic ulcer disease, hemophilia, impaired hemostasis, etc. should also be ruled out before the administration of this medicine.

Thrombocytopenia

Use of this medicine may cause low levels of platelets (thrombocytopenia). It is advised to monitor the blood platelet levels at regular intervals while this medicine is administered. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Other medicines

This medicine may interact with many other medicines and may cause severe side effects. Hence, you are advised to report the use of all medicines including herbs and supplements to the doctor before beginning treatment with this medicine.

Interchangeability with other heparins

This medicine should not be used interchangeably with other low molecular weight heparins.

Other uses

This medicine may be used for other blood clotting related indications based on the suitability of use and clinical evidence present.

Missed Dose

This medicine is usually administered in a clinical or hospital setup. However, if you are administering it at home and miss a scheduled dose, then call your doctor immediately for further instructions.

Overdose

Seek emergency medical attention in case of an overdose or suspected overdose. Symptoms may include nosebleed, unusual bruising and bleeding, and the presence of blood in stool or urine.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Lisinopril

Aspirin

Diclofenac

Streptokinase

Dextran

Disease interactions

Hemophilia

This medicine should be administered with extreme caution in patients suffering from hemophilia or other bleeding disorders due to the increased risk of excessive bleeding.

Liver/kidney impairment

This medicine should be used with caution in patients having an impairment of normal liver/kidney function. Appropriate dose adjustments and frequent clinical monitoring are recommended for such patients. Replacement with a suitable alternative may be necessary based on the clinical condition.

Peptic ulcer disease

This medicine should be administered with extreme caution in patients with peptic ulcer disease due to the increased risk of excessive bleeding.
Food interactions
Information not available.
Lab interactions
Information not available.
Administer Troparin 3000 IU Injection exactly as instructed by the doctor. It should not be injected into the muscles. It is advised to administer this medicine under the supervision of a doctor in a clinical setup with regular monitoring of blood clotting time and other related parameters. Your doctor may ask you to undergo certain tests to determine the safety of use of this medicine.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine works by interfering with the normal clotting process and decreasing the clot forming ability of the blood.
Legal Status

Approved

Unknown

Approved

Unknown

Classification

Category

Heparins

Schedule

Schedule H

Certoparin - DrugBank [Internet]. Drugbank.ca. 2017 [cited 4 September 2017]. Available from:

https://www.drugbank.ca/drugs/DB09261

Fareed J e. Management of thrombotic and cardiovascular disorders in the new millenium. - PubMed - NCBI [Internet]. Ncbi.nlm.nih.gov. 2017 [cited 4 September 2017]. Available from:

https://www.ncbi.nlm.nih.gov/pubmed/12812377

Generic low-molecular-weight heparins: some practical considerations. - PubMed - NCBI [Internet]. Ncbi.nlm.nih.gov. 2017 [cited 4 September 2017]. Available from:

https://www.ncbi.nlm.nih.gov/pubmed/15630677

Jeske W e. Pharmacologic profile of certoparin. PubMed - NCBI [Internet]. Ncbi.nlm.nih.gov. 2017 [cited 4 September 2017]. Available from:

https://www.ncbi.nlm.nih.gov/pubmed/15992081

[Internet]. Novctrd.com. 2017 [cited 4 September 2017]. Available from:

https://www.novctrd.com/CtrdWeb/displaypdf.nov?trialresultid=2951
Loading related questions...

How will this medicine affect me?

Chat with verified doctors starting @ ₹99
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Something doesn’t feel right?
Report an error